TY - JOUR
T1 - Stability of Forskolin in Lipid Emulsions and Oil/Water Partition Coefficients
AU - Yamamura, Keiko
AU - Nakao, Makoto
AU - Yano, Kohji
AU - Miyamoto, Ken ichi
AU - Yotsuyanagi, Toshihisa
PY - 1991
Y1 - 1991
N2 - Forskolin (FK), a diterpenoid isolated from Coleus Forskohlii, underwent base-catalyzed hydrolysis, producing 7-deacetyl forskolin. The half-life at pH 7.0 and 25°C was 16 d. Because of its poor solubility in water and degradation, the drug was incorporated in lipid emulsions (soybean oil/water = 10.9/89.1 v/v, average diameter of the droplets, 204 nm). No degradation of the drug was found in the lipid emulsion up to 30 d. The distribution of FK in the lipid emulsions was investigated based on a three-phase model which assumes that the drug resides in the oil and water phases and at the oil/water interface. From the determination of bulk oil/water and lipid emulsion partition coefficients, the relative percentages of the drug in the oil droplets, in the aqueous phase and at the interface were 43.3, 4.9 and 51.3%, respctively. This distribution profile seems to be consistent with the improved stability of FK in the lipid emulsions where the drug residing in the oil phase and at the interface is well protected from hydrolysis. The FK lipid emulsions should be given more interest in access to preclinical and clinical tests because the drug was well stabilized in the formulation and the excipients used are acceptable to human subjects.
AB - Forskolin (FK), a diterpenoid isolated from Coleus Forskohlii, underwent base-catalyzed hydrolysis, producing 7-deacetyl forskolin. The half-life at pH 7.0 and 25°C was 16 d. Because of its poor solubility in water and degradation, the drug was incorporated in lipid emulsions (soybean oil/water = 10.9/89.1 v/v, average diameter of the droplets, 204 nm). No degradation of the drug was found in the lipid emulsion up to 30 d. The distribution of FK in the lipid emulsions was investigated based on a three-phase model which assumes that the drug resides in the oil and water phases and at the oil/water interface. From the determination of bulk oil/water and lipid emulsion partition coefficients, the relative percentages of the drug in the oil droplets, in the aqueous phase and at the interface were 43.3, 4.9 and 51.3%, respctively. This distribution profile seems to be consistent with the improved stability of FK in the lipid emulsions where the drug residing in the oil phase and at the interface is well protected from hydrolysis. The FK lipid emulsions should be given more interest in access to preclinical and clinical tests because the drug was well stabilized in the formulation and the excipients used are acceptable to human subjects.
UR - http://www.scopus.com/inward/record.url?scp=0025906740&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025906740&partnerID=8YFLogxK
U2 - 10.1248/cpb.39.1032
DO - 10.1248/cpb.39.1032
M3 - Article
AN - SCOPUS:0025906740
SN - 0009-2363
VL - 39
SP - 1032
EP - 1034
JO - Chemical and Pharmaceutical Bulletin
JF - Chemical and Pharmaceutical Bulletin
IS - 4
ER -